Keytruda

Keytruda

Product

by Merck & Co., Inc.

Heard in 49 episodes across 25 shows since Dec 2025

Keytruda is the brand name for pembrolizumab, a humanized monoclonal antibody and programmed cell death protein 1 (PD-1) immune-checkpoint inhibitor. It is used in cancer immunotherapy for many types of cancer and is administered by slow intravenous injection.

Discussed inMarkets71%AI & Tech10%Health & Science10%Business5%

Episodes

49
across 25 shows

This week

0
episodes on 0 shows

Expert statements

2
2 positive

Share of the conversation

Mentions of Keytruda per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.1‰0.2‰0.3‰Aug 24Sep 15Oct 8Oct 30Nov 21
Show the data
DayShare (7-day)Mentions
Aug 280.03‰2
Sep 20.05‰3
Sep 30.07‰2
Sep 80.07‰1
Sep 130.02‰1
Sep 300.01‰1
Oct 50.03‰2
Oct 100.03‰1
Oct 140.02‰1
Oct 160.03‰1
Oct 180.03‰1
Oct 190.03‰1
Oct 220.03‰1
Oct 230.05‰3
Oct 260.04‰1
Oct 270.07‰3
Oct 290.07‰1
Oct 300.06‰2
Nov 20.08‰3
Nov 90.02‰2
Nov 130.03‰2
Nov 170.03‰2
Nov 200.03‰2

The full trend: rank, tone and why it is trending →

Email alert

Email me when Keytruda comes up on a podcast

One email a week at most, with the new episodes that mention Keytruda. Free, no account needed, unsubscribe in one click.

What experts have said about Keytruda

2 statements · 2 positive

  1. Andrew JosephPositiveOct 30, 2026· The Readout Loud

    Lower-priced copycat versions of Keytruda will become available within a few years.

    “in a few years, we're going to have copycat versions of drugs like Keytruda that will be available hopefully at much lower prices”

    Listen at 5:04

    Open the episode · 419: Assessing Merck and Moderna's mRNA cancer vaccine
  2. David WainerPositiveSep 13, 2026· WSJ's Take On the Week

    Keytruda is pharma’s best-selling drug, generating over $30 billion annually.

    “the best-selling drug in pharma right now is a drug called Keytruda. It's a cancer drug. It sells over $30 billion a year”

    Listen at 25:31

    Open the episode · A Breakthrough Cancer Vaccine Fueled a Biotech Rally. Can It Last?

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

49 episodes featuring Keytruda, newest first